Chief Commercial and Business · CervoMed Inc. · CervoMed Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
19.1K
Price
—
Executed
Oct 22, 2026
Disclosed
Oct 23, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Oct 22 executedOct 23, 2026 disclosed
CRVO · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Winton Matthew filed this Form 4 reporting a grant or award of CRVO on Oct 22, 2026. It became public on Oct 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Commercial and Business
Winton Matthewcik:0001971400
Issuer
CervoMed Inc.cik:0001053691
Revision history · 0
No field has changed since this record was first ingested.
